Consequently, we hypothesized that HIF-1α stabilization in MSCs would enhance their therapeutic efficacy in experimental lung injury and pneumonia, potentially by improving cell survival in the face of inflammatory, cytotoxic stimuli. Here, HIF1A is linked to susceptibility to pneumonia measurement.